
Lyophilized peptide · 5MG · Lot-tested · For research use only
Lab Tested
14-point panel
Made in USA
cGMP-aligned
Fast Shipping
Same/next day
AOD-9604
Modified GH fragment studied for lipolysis and fat-metabolism research.
Analytical Reports
Verify a batch →- ✓Lot HLX-011-A99.4%COA
About AOD-9604
AOD-9604 is a modified fragment of the C-terminus of human growth hormone (176-191). It is studied for its role in stimulating lipolysis and inhibiting lipogenesis without affecting blood-sugar or growth pathways in research models.
For research use only. This product is intended strictly for laboratory research and is not for human or veterinary use. It is not a drug, food, or cosmetic and is not intended to diagnose, treat, cure, or prevent any disease.
SPECIFICATIONS
- Purity
- ≥ 99%
QUALITY STANDARDS
- Greater than 99% purity
- LPS / endotoxins screened
- Heavy metals tested
- Sterility guaranteed
SOURCING STANDARDS
- Raw ingredients from an FDA-registered, cGMP-audited supplier.
- Finished peptides 0.22µm sterile-filtered and aseptically produced in a GMP facility.
- Tested by a US FDA-registered, ISO/IEC-accredited third-party analytical lab.
HEALIX vs THE COMPETITION
| Healix | Typical Competitor | |
|---|---|---|
| Pricing | ✓ Competitive | ✕ Often overpriced |
| Testing | ✓ Third-party verified COAs | ✕ No testing or first-party only |
| Batch transparency | ✓ Public COA lookup | ✕ None |
| Shipping | ✓ Same / next-day | ✕ Varies |
Always quality-tested, verified with third-party COAs
Every batch is screened across four characteristics — identity, purity, sterility, and endotoxicity — with an independent Certificate of Analysis to verify each result.
Identity
Confirmed by mass spectrometry
Purity
Quantified by reverse-phase HPLC
Sterility
0.22µm sterile-filtered, aseptic fill
Endotoxicity
LPS / endotoxin screened
Reviews
No reviews yet.
Share your research experience to help others.
Products you may like

5-Amino-1MQ
Small-molecule NNMT inhibitor researched for metabolic and adipose studies.

Semaglutide
GLP-1 receptor agonist studied extensively in metabolic research models.

Tirzepatide
Dual GIP/GLP-1 receptor agonist researched for metabolic pathways.

Retatrutide
Triple GIP/GLP-1/glucagon receptor agonist studied for metabolic research.